title: Cloning and characterization of the promoter for the human complement factor I (C3b/C4b inactivator) gene.
abstract: Complement factor I is a serine proteinase that regulates the classical and alternative pathways of complement by cleaving C3b and C4b and preventing the assembly of C3 and C5 convertase enzymes. In order to understand the regulation of factor I gene expression in liver cells, 4kb of the 5' flanking region of the gene was cloned, and the 1474-bp 3'-end was sequenced and shown to contain a number of transcription factor consensus sequences. A major and two minor transcription start sites were identified, respectively, at 152, 178, and 198bp upstream of the translation start site by primer extension analysis. The transcriptional activity of the 1474-bp fragment was analyzed by fusion of 5' deletion constructs to a cat-encoding gene expression vector and transient transfections into Hep G2 cells. A 273-bp fragment located at -112 to +161 relative to the major transcription start site was sufficient for promoter activity. The 3' fragment spanning +3 to +161 and containing a TATA-like element did not demonstrate promoter activity, suggesting that the core promoter resides in a 115-bp sequence located between -112 and +3. This region contains an Inr-like element overlapping the major cap site and a CTF-NF1 element, two potential CCAAT boxes and an AP-2 element partially overlapping an Sp-1 site. Thus, factor I promoter may belong to the TATA-less Inr-driven class II promoters whose transcription is regulated by Sp-1. The transcriptional activity of the 1474-bp 5' flanking fragment was upregulated by PMA, IL-6 and TNF-alpha, suggesting that factor I may be an acute phase reactant.
authors.affiliation: Department of Cellular, Molecular Pathology, Medical Sciences Building, University of Toronto, Toronto, Canada. joe.minta@utoronto.ca
authors.forename: J O
authors.initials: JO
authors.lastname: Minta
authors.forename: M
authors.initials: M
authors.lastname: Fung
authors.forename: S
authors.initials: S
authors.lastname: Turner
authors.forename: R
authors.initials: R
authors.lastname: Eren
authors.forename: L
authors.initials: L
authors.lastname: Zemach
authors.forename: M
authors.initials: M
authors.lastname: Rits
authors.forename: G
authors.initials: G
authors.lastname: Goldberger
mesh_terms: D001483:Base Sequence; D003001:Cloning, Molecular; D017244:Complement Factor I / Q000235:genetics*; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D015850:Interleukin-6 / Q000494:pharmacology; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000235:genetics; D011994:Recombinant Proteins / Q000494:pharmacology; D012091:Repetitive Sequences, Nucleic Acid; D016385:TATA Box; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014158:Transcription, Genetic; D014162:Transfection; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D015854:Up-Regulation
chemical_list: D007375:Interleukin-1; D015850:Interleukin-6; D012333:RNA, Messenger; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D017244:Complement Factor I; D013755:Tetradecanoylphorbol Acetate